Product Description
Mistovate-F 250 is a prescription-only combination medication from Healthgate formulated as a dry powder for inhalation. It contains two active ingredients that work in different ways to help manage and control chronic breathing disorders. This medicine is primarily used for the regular maintenance treatment of asthma and Chronic Obstructive Pulmonary Disease (COPD) to improve lung function and reduce symptoms like shortness of breath and wheezing. The medication is enclosed in capsules and must be administered using a compatible dry powder inhaler device.
Product Composition
The packaging indicates that each capsule contains a dry powder for inhalation with the following active ingredients:
-
Formoterol Fumarate: A long-acting bronchodilator.
-
Fluticasone Propionate: A corticosteroid with anti-inflammatory properties.
-
Quantity: 30 Capsules per pack.
The exact dosage strength of each ingredient (e.g., mcg) is not explicitly visible on the main face of the packaging in this image, but the product name “Mistovate-F 250” typically refers to the combined strength.
Summary
Mistovate-F 250 is a combined inhaler treatment for patients with chronic asthma or COPD. By combining a medication that opens the airways with a medication that reduces inflammation, it aims to reduce the severity and frequency of symptoms when used regularly. This product is for long-term maintenance therapy and must not be used to treat a sudden, acute asthma attack or COPD flare-up.
Pros and Cons
| Pros |
Cons |
| Fixed-Dose Combination: Delivers both necessary medicines (bronchodilator and steroid) in a single convenient dose, which can help patients adhere to their treatment. |
Not for Acute Symptoms: It is a maintenance medication only. A separate, short-acting rescue inhaler is required for immediate relief from a sudden attack. |
| Sustained Control: Designed to provide sustained bronchodilation and reduce underlying inflammation with twice-daily dosing, helping to prevent exacerbations. |
Risk of Oral Thrush: Use of inhaled corticosteroids increases the risk of developing a fungal infection in the mouth. |
| Improved Lung Function: Intended to significantly improve overall lung function and enhance a patient’s quality of life when used consistently. |
Side Effects: Potential side effects may include headache, hoarseness, throat irritation, dizziness, or a racing heartbeat. |
|
Requires a DPI Device: The capsules cannot be swallowed and require a compatible Dry Powder Inhaler (DPI) device (not pictured) for proper administration. |
How to Use
WARNING: DO NOT SWALLOW THESE CAPSULES. This medication must be used ONLY with a compatible dry powder inhaler device.
-
Prepare the DPI Device: Ensure you have the specific dry powder inhaler device recommended by your healthcare provider. Open the inhaler according to the manufacturer’s instructions.
-
Load the Capsule: Just before use, remove one Mistovate-F 250 capsule from the blister pack. Place it into the capsule chamber of the inhaler. Close the inhaler device, then puncture the capsule as directed by the device’s guidelines.
-
Breathe Out: Breathe out as completely as possible. Do not breathe out into the inhaler device.
-
Inhale: Hold the inhaler horizontally. Put your mouth over the mouthpiece and close your lips tightly around it. Take a single, quick, and deep breath in through your mouth to draw the powder from the capsule into your lungs.
-
Hold Your Breath: Remove the inhaler from your mouth and hold your breath for about 10 seconds, or as long as is comfortable.
-
Confirm and Empty: Open the device to check the capsule. If there is still powder inside, repeat the inhalation process from step 3. Once the capsule is empty, discard the capsule shell.
-
Post-Inhalation Care: Close the device. Rinsing your mouth with water and spitting it out immediately after each dose is crucial to help prevent throat irritation and oral thrush. Do not swallow the water.
